An experimental drug being developed by Sanofi significantly curbed progression of aortic valve stenosis, a common heart ...
An FDA vaccine advisory committee meeting to discuss next season’s flu vaccine has been canceled, potentially delaying the ...
The company's molecular research and drug-development platform taps what it calls nature's wisdom to drive the discovery of ...
An experimental drug originally developed by Sanofi that is now being advanced by the Mayo Clinic significantly curbed ...
Stocks like Schaeffler India, GE Power India, Coal India, Servotech Renewable Power System, Chemplast Sanmar, Rail Vikas ...
Detailed results presented at a medical congress help reinforce analyst expectations the drug, called duvakitug, will be ...
An experimental drug, ataciguat, initially created by Sanofi and further developed by the Mayo Clinic, has significantly ...
AV0328, one of Alopexx’s lead candidates, is a synthetic PNAG vaccine that has completed a phase 1 trial. The biotech is ...
Sanofi & Teva's IBD drug duvakitug shows promise in Phase 2b with €1B sales potential by 2032, faces competition from Roivant ...
Sanofi's Sarclisa (isatuximab) has gained approval from Japan’s MHLW for use in conjunction with VRd to treat newly diagnosed ...
The FDA’s abrupt decision to cancel next month’s vaccine advisory committee meeting is raising concerns about whether the U.S ...
Enveda, a Colorado-based biotech, has received a $20 million investment from French pharma major Sanofi. According to Enveda, ...